Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecebc54292ba538ce460b85feded62ec |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate |
2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_987ec26e7bc75c48ba61a009bc524998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea446622117d5ae2a7713d2d68e693c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_909686413ab8cd6b8c1f66ef81174889 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a317847665073a6ffbb28a08b6c50d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f146af0967a8bc2079705509cc90cb |
publicationDate |
2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2766239-C |
titleOfInvention |
Medicinal carbohydrates for treatment of respiratory conditions |
abstract |
The present invention relates to a method and compounds of Formula (1) and/or (2) or their pharmaceutically acceptable inorganic or organic salt thereof, and their compositions for treating respiratory conditions including post viral/bacterial infections, acute/chronic bronchitis, COPD, cystic fibrosis, and inflammatory conditions. It has been found by the applicants that the compounds of Formula (1) and/or (2) or their pharmaceutically acceptable inorganic or organic salt thereof could speed up the recovery of the viability of damaged respiratory tract cells by restoring sialylglyco- conjugates on their surface. |
priorityDate |
2009-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |